These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1698 related articles for article (PubMed ID: 24833797)

  • 21. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
    Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
    Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta.
    Behmoaras J; Slove S; Seve S; Vranckx R; Sommer P; Jacob MP
    Rejuvenation Res; 2008 Oct; 11(5):883-9. PubMed ID: 18803461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor β
    Xia XD; Peng YP; Lei D; Chen WQ
    Cell Biochem Funct; 2019 Apr; 37(3):193-202. PubMed ID: 30917408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration.
    Walker J; Undem C; Yun X; Lade J; Jiang H; Shimoda LA
    Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27009277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin-1 induces lysyl oxidase expression in pulmonary artery smooth muscle cells.
    Maruyama H; Sakai S; Dewachter L; Dewachter C; Rondelet B; Naeije R; Ieda M
    Can J Physiol Pharmacol; 2020 Sep; 98(9):629-636. PubMed ID: 32615041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
    Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.
    Lan B; Hayama E; Kawaguchi N; Furutani Y; Nakanishi T
    PLoS One; 2015; 10(1):e0117211. PubMed ID: 25629315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
    Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats.
    Vieillard-Baron A; Frisdal E; Raffestin B; Baker AH; Eddahibi S; Adnot S; D'Ortho MP
    Hum Gene Ther; 2003 Jun; 14(9):861-9. PubMed ID: 12828857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F
    Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
    Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
    Lung; 2007; 185(5):303-308. PubMed ID: 17721804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Ambalavanan N; Oparil S
    Life Sci; 2006 Aug; 79(14):1357-65. PubMed ID: 16714036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
    He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
    Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia.
    Wojciak-Stothard B; Zhao L; Oliver E; Dubois O; Wu Y; Kardassis D; Vasilaki E; Huang M; Mitchell JA; Harrington LS; Prendergast GC; Wilkins MR
    Circ Res; 2012 May; 110(11):1423-34. PubMed ID: 22539766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of epidermal growth factor inhibition in experimental pulmonary hypertension.
    Dahal BK; Cornitescu T; Tretyn A; Pullamsetti SS; Kosanovic D; Dumitrascu R; Ghofrani HA; Weissmann N; Voswinckel R; Banat GA; Seeger W; Grimminger F; Schermuly RT
    Am J Respir Crit Care Med; 2010 Jan; 181(2):158-67. PubMed ID: 19850946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Phosphatidylinositol 3-Kinase/Akt Signaling Attenuates Hypoxia-Induced Pulmonary Hypertension Through the Downregulation of Lysyl Oxidase.
    Xia XD; Lee J; Khan S; Ye L; Li Y; Dong L
    DNA Cell Biol; 2016 Oct; 35(10):599-606. PubMed ID: 27383273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.